Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd.（GLMD）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
glmd · 股价预测 · 16 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 16 位华尔街分析师
Buy
16 位分析师
共识
评级分布
12 个月目标价
High
$0.00
Consensus
$0.00
+0.0% upside
Low
$0.00
Median: $0 · Last Close: $0.47
短期股价预测
在 ±3 天财报窗口期内暂停短期预测，以避免不可靠信号。
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $0 | -50.0% |
| 2028 | $0 | -62.5% |
| 2029 | $0 | -67.2% |
| 2030 | $0 | -69.2% |
| 2031 | — | -70.2% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · GLMD · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2025-04-04 | Maxim Group | Downgrade ↓ | Buy→Hold |
| 2023-07-24 | Maxim Group | Upgrade ↑ | Hold→Buy |
| 2022-08-08 | Maxim Group | Downgrade ↓ | Buy→Hold |
| 2022-08-08 | Canaccord Genuity | Downgrade ↓ | Buy→Hold |
| 2022-05-18 | Raymond James | Downgrade ↓ | Outperform→Market Perform |
| 2022-05-03 | Raymond James | Maintains | Outperform→Outperform |
| 2022-05-03 | HC Wainwright & Co. | Downgrade ↓ | Buy→Neutral |
| 2021-05-17 | Canaccord Genuity | Maintains | Buy→Buy |
| 2021-03-19 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2021-01-08 | Raymond James | Maintains | Outperform→Outperform |
Wall Street analysts have recently issued updated ratings on Galmed Pharmaceuticals Ltd. (GLMD) stock. Of the recent 32 rating actions, 2 were upgrades and 8 were downgrades. 16 analysts currently cover GLMD.
分析师推荐趋势
GLMD analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 0 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$6M
↑ 14.3% YoY
Revenue Next Year
$6M
↑ 1.4% YoY
EPS This Year
$-1.56
EPS Next Year
$-0.90
↓ 42.3% YoY
EPS ForecastReported vs Estimated
Analysts forecast GLMD EPS of $-1.56 for the current fiscal year, based on estimates from 1 analysts. The GLMD revenue forecast is $6M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
GLMD 股价预测由两类独立数据源支撑：来自 16 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。GLMD 的共识目标价为 $0.00（+0.0% 上行空间），分析师共识为 Buy。
GLMD 对 2027 年的股价预测均值为 $0。 GLMD 对 2030 年的预测区间为 $0–$0。
Galmed Pharmaceuticals Ltd. 在 NASDAQ 上市，代码 GLMD。GLMD 在 2027 年的整体展望偏积极，在覆盖分析师中约 63% 对应 Buy 共识。
常见问题
GLMD 预测 · 8 个问题根据 16 位华尔街分析师，GLMD 的 12 个月平均目标价为 $0.00，最高 $0.00、最低 $0.00。若有图表，中位目标价可在上方查看。相对当前价 $0.47，隐含约 +0.0% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.